Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions.

Abstract

BACKGROUND:

The long-term clinical benefit after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in patients with total occlusions (TOs) and complex coronary artery disease has not yet been clarified.

OBJECTIVES:

The objective of this analysis was to assess 10-year all-cause mortality in patients with TOs undergoing PCI or CABG.

METHODS:

This is a subanalysis of patients with at least 1 TO in the SYNTAXES (Synergy Between PCI With Taxus and Cardiac Surgery Extended Survival) study, which investigated 10-year all-cause mortality in the SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) trial, beyond its original 5-year follow-up. Patients with TOs were further stratified according to the status of TO recanalization or revascularization.

RESULTS:

Of 1,800 randomized patients to the PCI or CABG arm, 460 patients had at least 1 lesion of TO. In patients with TOs, the status of TO recanalization or revascularization was not associated with 10-year all-cause mortality, irrespective of the assigned treatment (PCI arm: 29.9% vs. 29.4%; adjusted hazard ratio [HR]: 0.992; 95% confidence interval [CI]: 0.474 to 2.075; p = 0.982; and CABG arm: 28.0% vs. 21.4%; adjusted HR: 0.656; 95% CI: 0.281 to 1.533; p = 0.330). When TOs existed in left main and/or left anterior descending artery, the status of TO recanalization or revascularization did not have an impact on the mortality (34.5% vs. 26.9%; adjusted HR: 0.896; 95% CI: 0.314 to 2.555; p = 0.837).

CONCLUSIONS:

At 10-year follow-up, the status of TO recanalization or revascularization did not affect mortality, irrespective of the assigned treatment and location of TOs. The present study might support contemporary practice among high-volume chronic TO-PCI centers where recanalization is primarily offered to patients for the management of angina refractory to medical therapy when myocardial viability is confirmed. (Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival [SYNTAXES]; NCT03417050; SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries [SYNTAX]; NCT00114972).

• Authors: Hideyuki Kawashima, Kuniaki Takahashi, Masafumi Ono, Hironori Hara, Rutao Wang, Chao Gao, Faisal Sharif, Michael J Mack, David R Holmes, Marie-Claude Morice, Stuart J Head, Arie Pieter Kappetein, Daniel J F M Thuijs, Milan Milojevic, Thilo Noack, Friedrich-Wilhelm Mohr, Piroze M Davierwala, Patrick W Serruys, Yoshinobu Onuma, SYNTAX Extended Survival Investigators
• Journal: Journal of the American College of Cardiology (J Am Coll Cardiol) Vol. 77 Issue 5 Pg. 529-540 (02 09 2021) ISSN: 1558-3597 [Electronic] United States
• PMID: 33538250 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2021 American College of Cardiology Foundation. All rights reserved.

Topics

• Coronary Occlusion (diagnosis, mortality, surgery)
• Coronary Vessels (diagnostic imaging, surgery)
• Europe (epidemiology)
• Female
• Follow-Up Studies
• Forecasting
• Humans
• Male
• Middle Aged
• North America (epidemiology)
• Percutaneous Coronary Intervention (mortality)
• Postoperative Period
• Risk Assessment (methods)
• Risk Factors
• Survival Rate (trends)
• Treatment Outcome
• Vascular Surgical Procedures (mortality)